Table 2 aCGH findings in 21 chordomas

From: Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation

Regions lost or gained in 5 cases a

Most frequently affected region per chromosome a

 

Cytogenetic location

Start–end (Mb)

Start–end (Mb)

Frequency

Examples of candidate genes

Copy number losses

 1p36.33–p11.1

0.65–124.15

6.70–26.05

0.57

RUNX3

  

60.20–67.35

0.57

 
  

74.85–82.85

0.57

 

 2q34–q37.3

212.15–242.81

214.95–242.81

0.33

 

 Chromosome 3

0.04–199.45

23.05–33.35

0.71

 
  

47.10–48.65

0.71

 

 Chromosome 4

0.01–191.25

0.01–1.25

0.43

 
  

20.20–31.50

0.43

 
  

89.70–108.25

0.43

 

 6p21.1

41.60–43.80

   

 7q11.22–q11.23

71.70–74.20

   

 8p12–p11.1

36.90–45.15

37.85–42.25

0.29

 

 9p24.3–q31.3

0.03–113.20

20.30–24.19

0.76

CDKN2A, CDKN2B

 9q33.3–q34.3

125.90–138.39

   

 Chromosome 10

0.06–135.39

11.80–12.40

0.81

 

 11p15.5–p15.3

0.07–12.20

   

 11p14.3–p11.2

24.75–47.95

   

 11q12.2–q13.2

61.00–67.70

   

 11q14.3–q25

89.85–134.43

106.95–107.70

0.38

ATM

 12p11.21–p11.1

31.25–35.35

   

 12q24.31

119.80–122.75

120.20–122.70

0.33

 

 Chromosome 13

17.92–114.12

53.05–66.55

0.33

 
  

77.40–89.70

0.33

 
  

111.95–114.12

0.33

 

 Chromosome 14

18.07–106.30

18.07–19.30

0.52

 

 15q11.2

19.78–20.32

   

 15q15.1–q21.1

38.70–42.90

40.60–41.15

0.29

TP53BP1 b

 16p13.3

0.01–5.00

   

 16p12.3–q24.3

18.15–88.70

82.40–86.10

0.52

 

 17p13.3–p11.1

0–22.15

0–4.85

0.48

TP53 b

 17q25.1–q21.3

69.00–78.39

   

 Chromosome 18

0.02–76.10

17.40–17.95

0.48

 

 19p13.3–p11

0.02–28.45

2.05–3.95

0.43

 

 19q13.11–q13.43

37.60–63.77

   

 20p11.21–q11.21

25.40–31.35

28.40–29.65

0.29

 

 21q22.2–q22.3

41.15–46.92

43.10–46.65

0.29

 

 Chromosome 22

14.44–49.46

38.79–40.65

0.67

CHEK2 b

 Xp22.33

0.06–2.65

0.06–2.65

0.29

 

 Yp11.2

7.65–8.95

   

 Yq11.22-q11.23

20.75–25.55

   

Copy number gains

 1q21.1–q25.2

142.95–176.10

   

 1q31.3–q43

197.45–239.20

201.20–202.35

0.38

 

 5p15.33

0.07–3.70

  

TERT

 5q31.1–q31.2

131.80–135.65

  

TGFBI

 5q35.1–q35.3

170.60–180.73

171.50–180.73

0.33

 

 6q25.3-q27

157.40–170.90

158.30–161.10

0.29

 
  

166.05–170.75

0.29

T

 Chromosome 7

0.04–158.62

28.05–29.90

0.52

 

 8q24.21–q24.22

130.55–135.15

   

 12p13.33–p12.1

1.55–26.10

1.65–5.55

0.33

CCND2b, FGF6b, SOX5b

 12q13.11–q13.13

46.40–51.55

  

COL2A1

 15q11.2

19.10–20.05

   

 16q21–q22.2

61.30–69.45

63.65–68.50

0.29

 

 19p13.3–p13.2

4.00–8.55

   

 19q12–q13.43

34.40–63.77

47.70–48.30

0.33

TGFB1 b

 20q11.21–q13.12

31.40–41.90

35.40–36.80

0.29

E2F1b, SRC

 20q13.33

59.20–62.43

59.90–61.60

0.29

 
  1. aCGH=array comparative genomic hybridisation.
  2. aRegions <500 kb are excluded.
  3. bGenes located within the regions lost or gained in five cases, but outside of the most frequently affected region.